Saniwash Antimicrobial label

Saniwash Antimicrobial

Saniwash Antimicrobial Recall

Get an alert when a recall is issued.

Add Info

Side Effects & Adverse Reactions

Not for use in humans. Keep this and all medications out of reach of children. Consult a physician in case of accidental ingestion by humans. In case of accidental skin contact, wash area thoroughly with water. Avoid contact to the eyes.

Add Info

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Add Info

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

Add Info

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Add Info

Uses

Indication:

OSURNIA is indicated for the treatment of otitis externa in dogs associated with susceptible strains of bacteria (Staphylococcus pseudintermedius) and yeast (Malassezia pachydermatis).

Add Info

History

There is currently no drug history available for this drug.

Add Info

Other Information

OSURNIA contains 10 mg florfenicol, 10 mg terbinafine and 1 mg betamethasone acetate per mL and the inactive ingredients propylene carbonate, glycerol formal, hypromellose, phospholipid, oleic acid and BHT in an off-white to slightly yellow translucent gel.

Indication:

OSURNIA is indicated for the treatment of otitis externa in dogs associated with susceptible strains of bacteria (Staphylococcus pseudintermedius) and yeast (Malassezia pachydermatis).

Add Info
Add to My Alerts
Report Side Effect
Leave a Review

Is this a good medication?

Rated 4 out of 5
4.00
out of Five Stars
1
Rating(s)
Navigate to :
Saniwash Antimicrobial Recall
Side Effects & Adverse Reactions
Legal Issues
FDA Safety Alerts
Manufacturer Warnings
FDA Labeling Changes
Uses
History
Other Information
Manufacturers
Trending Topics

Saniwash Antimicrobial Manufacturers

  • Safetec Of America, Inc.
    Saniwash Antimicrobial | Novartis Animal Health Us, Inc.
    No Recall

    Saniwash Antimicrobial | Novartis Animal Health Us, Inc.

    Saniwash Antimicrobial | Novartis Animal Health Us, Inc.

    OSURNIA should be administered in the clinic. Clean and dry the external ear canal before administering the initial dose of the product. Administer one dose (1 tube) per affected ear(s) and repeat administration in 7 days.

    Do not clean the ear canal for 45 days after the initial administration to allow contact of the gel with the ear canal. Cleaning the ear may affect product effectiveness (see Effectiveness). If alternative otic therapies are required it is recommended to clean the ear(s) before application.

    Open tube by twisting  the soft tip.  Insert the flexible tip into the affected external ear canal(s) and squeeze entire tube contents into the external ear canal(s). After application, gently massage the base of the ear to allow the gel to penetrate to the lower part of the ear canal.

Login To Your Free Account